CENTERS FOR MEDICARE & MEDICAID SERVICES

Amendments

Health: reduce prescription drug prices, facilitate entry of generic and biosimilar products into the market, strengthen Federal exchanges, and reverse extension of short-term health plans (H.R. 987), H3873, H3874, H3876, H3877, H3878, H3879, H3880, H3882, H3883, H3884, H3885, H3886, H3887, H3888, H3889, H3891, H3892, H3893, H3894, H3896, H3897, H3898, H3900, H3901 [16MY]

——— reduce prescription drug prices, facilitate entry of generic and biosimilar products into the market, strengthen Federal exchanges, and reverse extension of short-term health plans (H.R. 987), consideration (H. Res. 377), H3811 [15MY]

Bills and resolutions

Dept. of HHS: establish a national telehealth program (see S. 2408), S5249 [31JY] (see H.R. 4900), H8594 [29OC]

——— establish an interagency council on social determinants of health to provide recommendations and assistance in developing strategies to target health and well-being of high-need patients (see S. 2986), S6888 [5DE] (see H.R. 4004), H7464 [25JY]

——— improve health outcomes in communities through community-relevant health information and new health supporting incentives and programs (see H.R. 660), H717 [17JA]

——— issue and disseminate guidance to States to clarify strategies to address social determinants of health under Medicaid and State Children’s Health Insurance Program (see H.R. 4621), H8101 [8OC]

——— reduce racial disparities in maternal mortality and morbidity through supporting implicit bias training, pregnancy medical home programs, and incorporating bias recognition in medical school skills testing (see S. 1600), S3059 [22MY] (see H.R. 2902), H4117 [22MY]

Diseases and disorders: accelerate progress toward prevention strategies, treatments, and a cure for Alzheimer’s disease and related dementias and provide caregivers dementia care training (see S. 1126), S2386 [10AP] (see H.R. 2283), H3255 [10AP]

Drugs: require drug manufacturers to disclose prices of prescription drugs in any direct-to-consumer advertising and marketing to practitioners of a drug (see H. Con. Res. 55), H7377 [24JY]

Government regulations: repeal requirement for unique health identifiers (see S. 2538), S5663 [24SE]

Health: reduce prescription drug prices, facilitate entry of generic and biosimilar products into the market, strengthen Federal exchanges, and reverse extension of short-term health plans (H.R. 987), consideration (see H. Res. 377), H3787 [14MY]

Health care facilities: expand use of global payments to rural hospitals (see S. 2157), S4947 [18JY]

——— extend enforcement instruction on supervision requirements for outpatient therapeutic services in critical access and small rural hospitals (see S. 895), S2042 [27MR]

Information technology: test effect of including telehealth services in Medicare health care delivery reform models (see S. 773), S1844 [13MR] (see H.R. 4013), H7464 [25JY]

Insurance: disapprove rule on definition of short-term limited duration insurance for purposes of its exclusion from the definition of individual health insurance coverage (see H.J. Res. 43), H1391 [6FE]

——— disapprove rule on waivers to States for alternatives to health insurance exchanges that weaken protections for individuals with preexisting conditions (see S.J. Res. 52), S5249 [31JY] (see H.J. Res. 74), H7488 [2AU]

——— provide that rule on definition of short-term limited duration insurance for purposes of its exclusion from the definition of individual health insurance coverage shall have no force or effect (see S. 1556), S3004 [21MY] (see H.R. 1010), H1390 [6FE]

Medicaid: extend certain spousal impoverishment protections, provide State option of coordinated care for children with medically complex conditions, and prevent misclassification of drugs in drug rebate program (see H.R. 1839), H2760 [21MR]

——— prevent misclassification of drugs for purposes of the drug rebate program (see S. 205), S586 [24JA] (see H.R. 937), H1341 [31JA]

——— support provision of treatment family care services (see S. 1880), S3651 [18JN] (see H.R. 3649), H5302 [9JY]

Medicare: apply secondary payer rules to certain workers’ compensation settlement agreements and qualified set-aside provisions (see H.R. 4161), H7488 [2AU]

——— conduct study on antipsychotic prescribing practices in nonnursing home settings (see H.R. 1955), H2915 [28MR]

——— encourage beneficiaries to voluntarily adopt advance directives guiding the medical care they receive (see S. 618), S1593 [28FE]

——— ensure home infusion therapy services are accessible to all beneficiaries regardless of the presence of a skilled professional (see H. Con. Res. 63), H7773 [18SE]

——— extend enforcement instruction on supervision requirements for outpatient therapeutic services in critical access and small rural hospitals (see H.R. 3431), H5075 [24JN]

——— extend Independence at Home Demonstration program (see H.R. 3644), H5302 [9JY]

——— extend work geographic index floor (see H.R. 3445), H5075 [24JN]

——— improve benchmarking process for Medicare Shared Savings Program (see S. 2648), S5922 [21OC] (see H.R. 5212), H9167 [21NO]

——— improve measurements under Skilled Nursing Facility Value-Based Purchasing (SNF VBP) Program (see H.R. 3406), H5036 [21JN]

——— provide greater transparency of discounts provided by drug manufacturers by establishing requirements for pharmacy-negotiated price concessions (see S. 2247), S5062 [24JY]

——— provide greater transparency of discounts provided by drug manufacturers by requiring Pharmacy Benefit Managers to disclose aggregate rebates and what proportion of those rebates go to beneficiaries (see S. 476), S1326 [13FE] (see H.R. 2115), H3127 [8AP]

——— provide relief for small rural hospitals from inaccurate instructions provided by certain administrative contractors (see H.R. 3672), H5583 [10JY]

——— remove exclusion of coverage for hearing aids and examinations (see H.R. 4618), H8101 [8OC]

Medicare/Medicaid: improve access to care for beneficiaries through models tested under Center for Medicare & Medicaid Innovation (see H.R. 3910), H7240 [23JY]

Organ procurement organizations: improve transparency, evaluation, and accountability (see S. 2063), S4729 [9JY]

Patient and State Stability Fund: establish to stabilize individual and small group State insurance markets and lower patient costs (see H.R. 1510), H2366 [5MR]

Patient Protection and Affordable Care Act: provide Federal exchange outreach and educational activities (see H.R. 987), H1389 [6FE]

Letters

Dept. of HHS rule on waivers to States for alternatives to health insurance exchanges that weaken protections for individuals with preexisting conditions: Seema Verma, Centers for Medicare & Medicaid Services, S6223 [29OC]

Protecting Americans With Preexisting Conditions Act, H3536 [9MY]

Rule on definition of short-term limited duration insurance for purposes of its exclusion from the definition of individual health insurance coverage shall have no force or effect: several medical organizations, H3874 [16MY]

Motions

Health: reduce prescription drug prices, facilitate entry of generic and biosimilar products into the market, strengthen Federal exchanges, and reverse extension of short-term health plans (H.R. 987), H3904 [16MY]

Insurance: disapprove rule on waivers to States for alternatives to health insurance exchanges that weaken protections for individuals with preexisting conditions (S.J. Res. 52), S6220 [29OC]

Notices

Estimated budget effects of H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act, H3786 [14MY], H3921 [16MY]

Estimated budget effects of H.R. 1839, Medicaid Services Investment and Accountability Act, H2793 [25MR]

Remarks in House

Dept. of HHS: prohibit termination of health insurance coverage for enrollees not actively enrolled during the most recent enrollment period, H3876 [16MY]

——— report on Patient Protection and Affordable Care Act marketing and outreach programs, H3877 [16MY]

——— require navigators to receive training on how to assist consumers with Medicaid and State Children’s Health Insurance Program enrollment, H3886, H3887 [16MY]

——— require reports during annual open enrollment period on performance of the Federal exchange and the Small Business Health Options Program exchange, H3883 [16MY]

——— School-Based Health Centers funding through reductions in Centers for Medicare & Medicaid Services management funding, H4623–H4625 [12JN]

Health: reduce prescription drug prices, facilitate entry of generic and biosimilar products into the market, strengthen Federal exchanges, and reverse extension of short-term health plans (H.R. 987), H3715 [10MY], H3731 [14MY], H3800 [15MY], H3851, H3852, H3853–H3911, H3913 [16MY], H4123 [23MY], H4401 [11JN], H5085 [25JN], H5175 [26JN], H7693 [12SE], H9248 [4DE], E623 [17MY]

——— reduce prescription drug prices, facilitate entry of generic and biosimilar products into the market, strengthen Federal exchanges, and reverse extension of short-term health plans (H.R. 987), consideration (H. Res. 377), H3801–H3813 [15MY]

——— reduce prescription drug prices, facilitate entry of generic and biosimilar products into the market, strengthen Federal exchanges, and reverse extension of short-term health plans (H.R. 987), corrections in engrossment, H3911 [16MY]

——— reduce prescription drug prices, facilitate entry of generic and biosimilar products into the market, strengthen Federal exchanges, and reverse extension of short-term health plans (H.R. 987), motion to recommit, H3908, H3909 [16MY]

HealthPartners (organization): Centers for Medicare & Medicaid Services Health Equity Award recipient, H2686 [13MR]

Insurance: prohibit funding to implement, administer, or enforce rule on definition of short-term limited duration insurance for purposes of its exclusion from the definition of individual health insurance coverage, H4569, H4570 [12JN]

——— provide that rule on definition of short-term limited duration insurance for purposes of its exclusion from the definition of individual health insurance coverage shall have no force or effect, H3859, H3863–H3865, H3867 [16MY]

Medicaid: extend certain spousal impoverishment protections, provide State option of coordinated care for children with medically complex conditions, and prevent misclassification of drugs in drug rebate program (H.R. 1839), H2773–H2780, H2781 [25MR], H3224 [10AP], E354 [26MR]

Medicare: provide greater transparency of discounts provided by drug manufacturers by requiring Pharmacy Benefit Managers to disclose aggregate rebates and what proportion of those rebates go to beneficiaries (H.R. 2115), H8516–H8519 [28OC], E1366 [29OC], E1383 [31OC]

Patient Protection and Affordable Care Act: navigator program funding, H4570, H4571 [12JN]

Pharmaceuticals: implement strategy to reduce prescription drug prices, H3658–H3661 [9MY]

Remarks in Senate

Dept. of HHS: establish a national telehealth program (S. 2408), S6383 [5NO]

Diseases and disorders: accelerate progress toward prevention strategies, treatments, and a cure for Alzheimer’s disease and related dementias and provide caregivers dementia care training (S. 1126), S2599 [2MY]

Health: reduce prescription drug prices, facilitate entry of generic and biosimilar products into the market, strengthen Federal exchanges, and reverse extension of short-term health plans (H.R. 987), S6934 [10DE]

HealthPartners (organization): Centers for Medicare & Medicaid Services Health Equity Award recipient, S1272 [12FE]

Insurance: disapprove rule on waivers to States for alternatives to health insurance exchanges that weaken protections for individuals with preexisting conditions (S.J. Res. 52), S5680 [25SE], S5909–S5911 [21OC], S6082–S6086 [23OC], S6181 [28OC], S6206, S6208, S6210, S6223–S6225, S6228–S6234, S6235, S6236 [29OC], S6263–S6266, S6268–S6273 [30OC], S6347 [31OC]

——— provide that rule on definition of short-term insurance for purposes of its exclusion from the definition of individual health insurance coverage shall have no force or effect (S. 1556), unanimous-consent request, S3242, S3243 [5JN]

——— provide that rule on definition of short-term limited duration insurance for purposes of its exclusion from individual health insurance coverage shall have no force or effect (S. 1556), unanimous-consent request, S3035 [22MY]

——— provide that rule on definition of short-term limited duration insurance for purposes of its exclusion from the definition of individual health insurance coverage shall have no force or effect (S. 1556), S3035–S3037 [22MY], S3243–S3245 [5JN]

——— provide that rule on short-term limited duration insurance for purposes of its exclusion from the definition of individual health insurance coverage shall have no force or effect (S. 1556), unanimous-consent request, S6266, S6267 [30OC]

Medicaid: extend certain spousal impoverishment protections, provide State option of coordinated care for children with medically complex conditions, and prevent misclassification of drugs in drug rebate program (H.R. 1839), S2203 [2AP]

——— prevent misclassification of drugs for purposes of the drug rebate program (S. 205), S2470 [29AP], S5279 [1AU]

Medicare: proposed rule to update formula used to reimburse hospitals for patient care, S4834 [16JY]

Medicare/Medicaid: improve drug programs, protect from drastic increases in manufacturer drug prices, increase transparency of pharmacy benefit manager practices, and allow payment for certain treatments, S5121, S5126 [29JY], S5177 [30JY], S5207, S5221 [31JY], S5480 [12SE]

Organ donation: oppose certain policies relative to organ procurement, donations, and transplants, S903 [6FE]

Organ procurement organizations: improve transparency, evaluation, and accountability (S. 2063), S4732 [9JY]

Reports filed

Consideration of H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act: Committee on Rules (House) (H. Res. 377) (H. Rept. 116–61), H3787 [14MY]

Marketing and Outreach Restoration To Empower (MORE) Health Education Act: Committee on Energy and Commerce (House) (H.R. 987) (H. Rept. 116–53), H3725 [10MY]

Medicare Hearing Act: Committee on Ways and Means (House) (H.R. 4618) (H. Rept. 116–326), H9345 [6DE]

Rule on Definition of Short-Term Insurance for Purposes of Exclusion From Definition of Individual Health Insurance Coverage Shall Have No Force or Effect: Committee on Education and Labor (House) (H.R. 1010) (H. Rept. 116–43), H3302 [29AP]

——— Committee on Energy and Commerce (House) (H.R. 1010) (H. Rept. 116–43), H3725 [10MY]

Tables

Estimated pay-as-you-go effects of H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act, H3786 [14MY], H3921 [16MY]

Estimated pay-as-you-go effects of H.R. 1839, Medicaid Services Investment and Accountability Act, H2793 [25MR]

Texts of

H. Res. 377, consideration of H.R. 5, Equality Act, H.R. 312, Mashpee Wampanoag Tribe Reservation Reaffirmation Act, and H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act, H3801 [15MY]

H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act, H3868–H3873 [16MY]

H.R. 1839, Medicaid Services Investment and Accountability Act, H2773–H2776 [25MR]

H.R. 2115, Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act, H8516 [28OC]

S. 895, Rural Hospital Regulatory Relief Act, S2048 [27MR]